₹113.79
Above FV▼ -56.3% against the close used
Model range ₹4.47 – ₹203.53
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹4.47Fair value₹113.79Bull₹203.53
FairClose
52-week traded range
52W low ₹179.8952W high ₹294.15
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Viyash Scientific Limited closed at ₹260.45, 128.9% above the consensus fair value of ₹113.79 drawn from 9 valuation models.
Financial DNA score 37/100 — Average. P/E of 51.2x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹65.03
-75.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=1.1%, r=10%, tg=3%, n=10yr
Graham Number
₹87.33
-66.5%
√(22.5 × EPS × BVPS)
EPS=4.06, BVPS=83.48 · outside Graham range (P/E 51.2, P/B 3.1) — asset-light, treat as a rough floor
Graham Formula
₹40.34
-84.5%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=1.1%, FD=7%
P/E Fair Value
₹144.94
-44.3%
EPS × 35.7x (sector P/E)
EPS=4.06, Sector P/E=35.7x
Peter Lynch (PEG)
₹4.47
-98.3%
EPS × Growth% (PEG = 1 is fair)
EPS=4.06, g=1.1%
EV/EBITDA
₹203.53
-21.9%
(EBITDA × 10.6x − Net Debt) ÷ Shares
EBITDA=8.87B
Book Value (P/B)
₹52.35
-79.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=83.48, ROE=7.4%, g=3%, r=10%
Reverse DCF
₹260.45
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 22.9% | Historical: 1.1%
Margin of Safety
₹63.31
-75.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=84.41, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.